Case ReportCombined chemotherapy and radiotherapy during conception and first two trimesters of gestation in a woman with metastatic breast cancer
Introduction
Diagnosis of breast cancer during pregnancy is quite common. Seven percent of patients with breast cancer are younger than 40 years old, and an estimated 10% of all women aged between 25 and 40 years old are pregnant at any point [1]. Recent reports indicate that 0.75% to 3.1% of patients with breast cancer are pregnant or lactating at the time of diagnosis [2]. It is estimated that there is one case of breast cancer per 3000 pregnancies, and with the increasing trend for women to delay childbearing, the incidence rate tends to increase [3].
Use of chemotherapy during the first trimester increases the risk of spontaneous abortion, fetal death, and major malformations [4]. Chemotherapy should be avoided during the highly sensitive period of organogenesis, but according to present literature, it may be used during the second and third trimesters [4], [5]. Radiotherapy should also be avoided during pregnancy because of fetal congenital defects observed [6].
The experience with chemotherapy toxicity during conception and first trimester is limited. We present a case of a woman with metastatic breast cancer, who conceived during chemotherapy and underwent analgesic radiotherapy of the thoracic and lumbar spine during the 17th week of her pregnancy.
Section snippets
Case report
A 33-year-old woman came to our department with a locally advanced malignant neoplasm of her left breast. She was otherwise asymptomatic. On examination, her left breast was painless, hard, and irregular, with a retracted nipple and “peau d'orange” skin. A fixation of the bulky breast in the thoracic wall was observed. A block 3 × 5 cm of lymph nodes in the ipsilateral axilla and a supraclavicular lymph node were found. The mammography and the ultrasound examination confirmed the presence of a
Discussion
It is obvious that the patient conceived after the second chemotherapeutic cycle. Both the patient and her medical staff did not know about the pregnancy, so they did not discuss and debate this particular difficult situation. An anthracycline-based regimen rather than hormonal therapy was preferred as the first therapeutic approach because of the inflammatory nature of the primary breast tumor and because of the high bony spread of the metastatic disease. Cumulative doses of the cytotoxics
References (29)
- et al.
Use of chemotherapy during human pregnancy
Lancet Oncol.
(2004) - et al.
Transplacental passage of doxorubicin
Lancet
(1983) - et al.
Anthracyclines during pregnancy: embryo–fetal outcome in 160 patients
Ann. Oncol.
(2004) - et al.
Eclampsia after polychemotherapy for nodal-positive breast cancer during pregnancy
Eur. J. Obstet. Gynecol. Reprod. Biol.
(1996) - et al.
Radiotherapy during pregnancy: effects on fetuses and neonates
Clin. Ther.
(1997) - et al.
Tamoxifen as systemic treatment of advanced breast cancer during pregnancy—Case report and literature review
Gynecol. Oncol.
(2001) - et al.
Ambiguous genitalia in infant exposed to tamoxifen in utero
Lancet
(1997) - et al.
Malignant hypercalcaemia in pregnancy and antenatal administration of intravenous pamidronate
Clin. Oncol. (R. Coll. Radiol.)
(1996) - et al.
Combination chemotherapy and radiation for stage IV breast cancer during pregnancy
Gynecol. Oncol.
(1990) - et al.
Vinorelbine in pregnancy
Eur. J. Cancer
(1997)
Breast cancer and pregnancy
Arch. Surg.
Breast carcinoma and pregnancy
Management of breast cancer during pregnancy using a standardized protocol
J. Clin. Oncol.
Pharmacology of antineoplastic agents in pregnancy
Crit. Rev. Oncol. Hematol.
Cited by (43)
Cancer in pregnancy
2023, DiSaia and Creasman Clinical Gynecologic OncologyNeurocognitive outcomes following fetal exposure to chemotherapy for gestational breast cancer: A Canadian multi-center cohort study
2021, BreastCitation Excerpt :Standard treatments for premenopausal people with BC include all or some of the following; surgery, chemotherapy, hormonal therapy, biologic therapy (e.g. trastuzumab), and radiation therapy. Hormonal therapy, biologic therapy, and radiation therapy are generally avoided in pregnancy due to the risk of adverse effects on the fetus [4,6–8]. Surgery, under local or general anesthesia, has not been found to be associated with adverse pregnancy outcomes [4,9–11].
Viable Pregnancy in a patient with metastatic melanoma treated with double checkpoint immunotherapy
2018, Seminars in OncologyCancer in pregnancy
2018, Clinical Gynecologic OncologyAntineoplastic drugs
2015, Drugs During Pregnancy and Lactation: Treatment Options and Risk Assessment: Third EditionVitamins, minerals and trace elements
2015, Drugs During Pregnancy and Lactation: Treatment Options and Risk Assessment: Third Edition